U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938034) titled 'A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function' on July 02.

Brief Summary: This study is a Phase I, single-dose, open-label trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single dose of SYH2053 injection in participants with moderate, and severe renal impairment compared to participants with normal renal function.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Renal Impairment

Intervention: DRUG: SYH2053

subcutaneous injection

Recruitment Status: RECRUITING

Sponsor: CSPC Zhongnuo Pharmaceutical (...